After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more_老虎社区_美港股上老虎

After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more

StreetInsider2021-10-20

After-Hours Stock Movers:

Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.

ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance

WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.

Akero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).

Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.

United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.

Netflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

181

koolgal
·2021-10-20
If health care stocks are your favourites right now and wondering which one to buy, why not consider$Health Care Select Sector SPDR Fund(XLV)$ which covers the main health care stocks like Johnson and Johnson, Merck, Pfizer and more, all in 1 neat bundle ready to go! 👍😊🎊🎉🎊
回复
20
举报
收起
- koolgal:
  Do you have any ETF in your portfolio?
  2021-11-26
  回复
  举报
- koolgal:
  Yes I agree. Thanks for sharing
  2021-11-26
  回复
  举报
- 和小康:
  对不会选股的来说买ETF是个不错的选择！
  2021-11-26
  回复
  举报
查看更多 2 条评论
TeikLeong
·2021-10-20
Like
回复
3
举报
收起
- 来人:
  Done
  2021-10-20
  回复
  举报
Blessy
·2021-10-20
Like thks
回复
3
举报
收起
- Mml:
  Done
  2021-10-20
  回复
  举报
Kel9670ong
·2021-10-20
Nowsday biotech company seems to be doing well
回复
5
举报
收起
- Kel9670ong:
  time to sow from these company
  2021-10-20
  回复
  举报
- Ameliakoh:
  Yup
  2021-10-20
  回复
  举报
Leekeez
·2021-10-20
Ok
回复
3
举报
winterflower
·2021-10-20
Like pls thank you
回复
7
举报
收起
- TeikLeong:
  ok
  2021-10-20
  回复
  举报
- Blessy:
  Ok
  2021-10-20
  回复
  举报
- FreebigmoNeY:
  Ok
  2021-10-20
  回复
  举报
HENRYCSC
·2021-10-20
Like pls
回复
7
举报
收起
- Boo2bear:
  Done. Pls like back. Tq
  2021-10-20
  回复
  举报
Dreamchaser9
·2021-10-20
Ok
回复
4
举报
Elsontok
·2021-10-20
done
回复
4
举报
DMC8
·2021-10-20
Like pls
回复
7
举报
收起
- 小虎一飞冲天:
  👍🏼
  2021-10-20
  回复
  举报
- Dreamchaser9:
  Ok
  2021-10-20
  回复
  举报
kenong62
·2021-10-20
Please likeThanks
回复
11
举报
收起
- 滚股怪:
  Try
  2021-10-20
  回复
  举报
- ocean_wave:
  Hi
  2021-10-20
  回复
  举报
- DMC8:
  Ok
  2021-10-20
  回复
  举报
Zhen95
·2021-10-20
Like and comment
回复
6
举报
收起
- Zhen95:
  gd
  2021-10-21
  回复
  举报
- Huathk:
  Gd
  2021-10-20
  回复
  举报
- Zhen95:
  gd
  2021-10-20
  回复
  举报
查看更多 1 条评论
Sohws
·2021-10-20
Nice like pls thank you
回复
11
举报
收起
- Zhen95:
  gd
  2021-10-20
  回复
  举报
- rachhy:
  ok
  2021-10-20
  回复
  举报
JCai
·2021-10-20
K
回复
5
举报
收起
- JCai:
  mm
  2021-10-20
  回复
  举报
YCGan
·2021-10-20
Great
回复
6
举报
財神發
·2021-10-20
👍
回复
5
举报
Tanwilliam
·2021-10-20
Like
回复
9
举报
收起
- Sohws:
  Done
  2021-10-20
  回复
  举报
- stingray102:
  ok
  2021-10-20
  回复
  举报
- okkar:
  ✅
  2021-10-20
  回复
  举报
JoyceChew
·2021-10-20
👍🏻👍🏻👍🏻
回复
8
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://ttm.financial/m/news/2176104937?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-20 07:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2176104937","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","media":"StreetInsider","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LRN","symbol_name":"Stride","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","article_id":"2176104937","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","pubTimestamp":1634686382,"columns":[],"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"translate_title":"盘后股票市场：赛森生物、ATI物理治疗、WD-40公司等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9},"content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":859228352,"gmtCreate":1634701893711,"gmtModify":1634701893711,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"htmlText":"If health care stocks are your favourites right now and wondering which one to buy, why not consider<a href=\"https://laohu8.com/S/XLV\">$Health Care Select Sector SPDR Fund(XLV)$</a>&nbsp;which covers the main health care stocks like Johnson and Johnson, Merck, Pfizer and more, all in 1 neat bundle ready to go! 👍😊🎊🎉🎊","listText":"If health care stocks are your favourites right now and wondering which one to buy, why not consider<a href=\"https://laohu8.com/S/XLV\">$Health Care Select Sector SPDR Fund(XLV)$</a>&nbsp;which covers the main health care stocks like Johnson and Johnson, Merck, Pfizer and more, all in 1 neat bundle ready to go! 👍😊🎊🎉🎊","text":"If health care stocks are your favourites right now and wondering which one to buy, why not consider$Health Care Select Sector SPDR Fund(XLV)$ which covers the main health care stocks like Johnson and Johnson, Merck, Pfizer and more, all in 1 neat bundle ready to go! 👍😊🎊🎉🎊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":20,"commentSize":10,"repostSize":1,"link":"https://laohu8.com/post/859228352","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6724136,"gmtCreate":1637874459618,"gmtModify":1637874459618,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859228352,"type":1,"supId":6724083,"prevId":0,"content":"Do you have any ETF in your portfolio?","text":"Do you have any ETF in your portfolio?","html":"Do you have any ETF in your portfolio?"},{"id":6724131,"gmtCreate":1637874382517,"gmtModify":1637874382517,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859228352,"type":1,"supId":6724083,"prevId":0,"content":"Yes I agree. Thanks for sharing","text":"Yes I agree. Thanks for sharing","html":"Yes I agree. Thanks for sharing"},{"id":6724083,"gmtCreate":1637870860549,"gmtModify":1637870860549,"authorId":3471405853090759,"author":{"id":3471405853090759,"idStr":"3471405853090759","authorId":3471405853090759,"name":"和小康","avatar":"https://static.tigerbbs.com/384782e8989fba480367af2d2171a783","vip":1,"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859228352,"type":1,"supId":0,"prevId":0,"content":"对不会选股的来说买ETF是个不错的选择！","text":"对不会选股的来说买ETF是个不错的选择！","html":"对不会选股的来说买ETF是个不错的选择！"},{"id":6263047,"gmtCreate":1634715193793,"gmtModify":1634715193793,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859228352,"type":1,"supId":6262605,"prevId":0,"content":"Thanks 👍😊","text":"Thanks 👍😊","html":"Thanks 👍😊"},{"id":6262605,"gmtCreate":1634710410983,"gmtModify":1634710411023,"authorId":4091089381144950,"author":{"id":4091089381144950,"idStr":"4091089381144950","authorId":4091089381144950,"name":"滚股怪","avatar":"https://static.tigerbbs.com/b67621b4133ca0db91bff9766152a448","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859228352,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"CN"},{"id":859644652,"gmtCreate":1634695176387,"gmtModify":1634695262931,"author":{"id":"3581504913688063","authorId":"3581504913688063","name":"TeikLeong","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581504913688063","authorIdStr":"3581504913688063"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859644652","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6261030,"gmtCreate":1634699449957,"gmtModify":1634699449999,"authorId":3575544575320394,"author":{"id":3575544575320394,"idStr":"3575544575320394","authorId":3575544575320394,"name":"来人","avatar":"https://static.tigerbbs.com/0af89587decbb8a1d3e1596adc29cb98","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859644652,"type":1,"supId":0,"prevId":0,"content":"<u>Done</u>","text":"<u>Done</u>","html":"<u>Done</u>"}],"langContent":"CN"},{"id":859622164,"gmtCreate":1634693631820,"gmtModify":1634693753169,"author":{"id":"3579490777871937","authorId":"3579490777871937","name":"Blessy","avatar":"https://static.tigerbbs.com/44bb98bc862389e25317a0ced967170a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579490777871937","authorIdStr":"3579490777871937"},"htmlText":"Like thks&nbsp;","listText":"Like thks&nbsp;","text":"Like thks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859622164","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6260440,"gmtCreate":1634696445063,"gmtModify":1634696445184,"authorId":3584863771682470,"author":{"id":3584863771682470,"idStr":"3584863771682470","authorId":3584863771682470,"name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859622164,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"CN"},{"id":859687168,"gmtCreate":1634692754798,"gmtModify":1634692755791,"author":{"id":"3578468158955348","authorId":"3578468158955348","name":"Kel9670ong","avatar":"https://static.tigerbbs.com/bd86c42e207fbd94e7f8877a29457d71","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578468158955348","authorIdStr":"3578468158955348"},"htmlText":"&nbsp;Nowsday biotech company seems to be doing well","listText":"&nbsp;Nowsday biotech company seems to be doing well","text":"Nowsday biotech company seems to be doing well","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/859687168","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6262947,"gmtCreate":1634714047116,"gmtModify":1634714047144,"authorId":3578468158955348,"author":{"id":3578468158955348,"idStr":"3578468158955348","authorId":3578468158955348,"name":"Kel9670ong","avatar":"https://static.tigerbbs.com/bd86c42e207fbd94e7f8877a29457d71","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859687168,"type":1,"supId":6259697,"prevId":0,"content":"time to sow from these company","text":"time to sow from these company","html":"time to sow from these company"},{"id":6259697,"gmtCreate":1634693256427,"gmtModify":1634693256538,"authorId":3574754838536636,"author":{"id":3574754838536636,"idStr":"3574754838536636","authorId":3574754838536636,"name":"Ameliakoh","avatar":"https://static.tigerbbs.com/4a747ab791603fb0a649736b10ec7454","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859687168,"type":1,"supId":0,"prevId":0,"content":"Yup","text":"Yup","html":"Yup"}],"langContent":"CN"},{"id":859617037,"gmtCreate":1634692287555,"gmtModify":1634692288028,"author":{"id":"4089085863454690","authorId":"4089085863454690","name":"Leekeez","avatar":"https://static.tigerbbs.com/0dc7b69aff39f86a9dc2217fe596c9af","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4089085863454690","authorIdStr":"4089085863454690"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859617037","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":859614592,"gmtCreate":1634692274848,"gmtModify":1634692275072,"author":{"id":"3575500119873947","authorId":"3575500119873947","name":"winterflower","avatar":"https://static.tigerbbs.com/eeb88638c0d0fc78384e4f7a7514daaa","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575500119873947","authorIdStr":"3575500119873947"},"htmlText":"Like pls thank you&nbsp;","listText":"Like pls thank you&nbsp;","text":"Like pls thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/859614592","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6260121,"gmtCreate":1634695162033,"gmtModify":1634695162071,"authorId":3581504913688063,"author":{"id":3581504913688063,"idStr":"3581504913688063","authorId":3581504913688063,"name":"TeikLeong","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859614592,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":6259762,"gmtCreate":1634693620348,"gmtModify":1634693620382,"authorId":3579490777871937,"author":{"id":3579490777871937,"idStr":"3579490777871937","authorId":3579490777871937,"name":"Blessy","avatar":"https://static.tigerbbs.com/44bb98bc862389e25317a0ced967170a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859614592,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6259576,"gmtCreate":1634692783180,"gmtModify":1634692783305,"authorId":3578472903237510,"author":{"id":3578472903237510,"idStr":"3578472903237510","authorId":3578472903237510,"name":"FreebigmoNeY","avatar":"https://static.tigerbbs.com/3a31b93448657f6d83ec000012f9f9e6","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859614592,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":859638412,"gmtCreate":1634691379922,"gmtModify":1634691380747,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575091428590185","authorIdStr":"3575091428590185"},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859638412","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6259420,"gmtCreate":1634692084400,"gmtModify":1634692084440,"authorId":3578969648963961,"author":{"id":3578969648963961,"idStr":"3578969648963961","authorId":3578969648963961,"name":"Boo2bear","avatar":"https://static.tigerbbs.com/209ae746c8124fe2d5f79aee784d2fcc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859638412,"type":1,"supId":0,"prevId":0,"content":"Done. Pls like back. <u>Tq</u>","text":"Done. Pls like back. <u>Tq</u>","html":"Done. Pls like back. <u>Tq</u>"}],"langContent":"CN"},{"id":859691499,"gmtCreate":1634690674113,"gmtModify":1634690675417,"author":{"id":"3581782846197879","authorId":"3581782846197879","name":"Dreamchaser9","avatar":"https://static.tigerbbs.com/f4f8f000953179179078bdd5e6f748b6","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581782846197879","authorIdStr":"3581782846197879"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859691499","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":859605127,"gmtCreate":1634690305480,"gmtModify":1634690305683,"author":{"id":"3577246510298951","authorId":"3577246510298951","name":"Elsontok","avatar":"https://static.tigerbbs.com/5d91c4e73ceffea4b93c2c832535db3b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577246510298951","authorIdStr":"3577246510298951"},"htmlText":"done","listText":"done","text":"done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859605127","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":859608933,"gmtCreate":1634690134468,"gmtModify":1634690135811,"author":{"id":"3579992296424941","authorId":"3579992296424941","name":"DMC8","avatar":"https://static.tigerbbs.com/65aa8f5f6299558ce2ab36482793f750","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579992296424941","authorIdStr":"3579992296424941"},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/859608933","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6259067,"gmtCreate":1634690842922,"gmtModify":1634690843029,"authorId":3582098623642517,"author":{"id":3582098623642517,"idStr":"3582098623642517","authorId":3582098623642517,"name":"小虎一飞冲天","avatar":"https://static.tigerbbs.com/1a55a61195830e019abf5d3cc69681b9","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859608933,"type":1,"supId":0,"prevId":0,"content":"👍🏼","text":"👍🏼","html":"👍🏼"},{"id":6259035,"gmtCreate":1634690682349,"gmtModify":1634690682468,"authorId":3581782846197879,"author":{"id":3581782846197879,"idStr":"3581782846197879","authorId":3581782846197879,"name":"Dreamchaser9","avatar":"https://static.tigerbbs.com/f4f8f000953179179078bdd5e6f748b6","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859608933,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":859874453,"gmtCreate":1634689834517,"gmtModify":1634689837316,"author":{"id":"3574928367638029","authorId":"3574928367638029","name":"kenong62","avatar":"https://static.tigerbbs.com/37fd00bd8cea11b8aa1aed6d9ddd9413","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3574928367638029","authorIdStr":"3574928367638029"},"htmlText":"Please likeThanks","listText":"Please likeThanks","text":"Please likeThanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/859874453","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6262190,"gmtCreate":1634706893719,"gmtModify":1634706893837,"authorId":4091089381144950,"author":{"id":4091089381144950,"idStr":"4091089381144950","authorId":4091089381144950,"name":"滚股怪","avatar":"https://static.tigerbbs.com/b67621b4133ca0db91bff9766152a448","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859874453,"type":1,"supId":0,"prevId":0,"content":"Try","text":"Try","html":"Try"},{"id":6261755,"gmtCreate":1634703955545,"gmtModify":1634703955654,"authorId":3578971018458145,"author":{"id":3578971018458145,"idStr":"3578971018458145","authorId":3578971018458145,"name":"ocean_wave","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859874453,"type":1,"supId":0,"prevId":0,"content":"<u>Hi</u>","text":"<u>Hi</u>","html":"<u>Hi</u>"},{"id":6258913,"gmtCreate":1634690127957,"gmtModify":1634690127989,"authorId":3579992296424941,"author":{"id":3579992296424941,"idStr":"3579992296424941","authorId":3579992296424941,"name":"DMC8","avatar":"https://static.tigerbbs.com/65aa8f5f6299558ce2ab36482793f750","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859874453,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":859857887,"gmtCreate":1634688922522,"gmtModify":1634688923321,"author":{"id":"3575252907553393","authorId":"3575252907553393","name":"Zhen95","avatar":"https://static.tigerbbs.com/62a4767b8928f124a0f7f02bd3c21f62","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3575252907553393","authorIdStr":"3575252907553393"},"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/859857887","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6267720,"gmtCreate":1634748538061,"gmtModify":1634763833803,"authorId":3575252907553393,"author":{"id":3575252907553393,"idStr":"3575252907553393","authorId":3575252907553393,"name":"Zhen95","avatar":"https://static.tigerbbs.com/62a4767b8928f124a0f7f02bd3c21f62","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859857887,"type":1,"supId":6265394,"prevId":0,"content":"gd","text":"gd","html":"gd"},{"id":6265394,"gmtCreate":1634734497615,"gmtModify":1634736403062,"authorId":3573472992263411,"author":{"id":3573472992263411,"idStr":"3573472992263411","authorId":3573472992263411,"name":"Huathk","avatar":"https://static.tigerbbs.com/43c7168c646d9ea6805194ed0003f1cc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859857887,"type":1,"supId":0,"prevId":0,"content":"Gd","text":"Gd","html":"Gd"},{"id":6263397,"gmtCreate":1634718195216,"gmtModify":1634718901335,"authorId":3575252907553393,"author":{"id":3575252907553393,"idStr":"3575252907553393","authorId":3575252907553393,"name":"Zhen95","avatar":"https://static.tigerbbs.com/62a4767b8928f124a0f7f02bd3c21f62","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859857887,"type":1,"supId":6258820,"prevId":0,"content":"gd","text":"gd","html":"gd"},{"id":6258820,"gmtCreate":1634689817135,"gmtModify":1634689817169,"authorId":3574928367638029,"author":{"id":3574928367638029,"idStr":"3574928367638029","authorId":3574928367638029,"name":"kenong62","avatar":"https://static.tigerbbs.com/37fd00bd8cea11b8aa1aed6d9ddd9413","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859857887,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"CN"},{"id":859853154,"gmtCreate":1634688607254,"gmtModify":1634688607736,"author":{"id":"3566383987360583","authorId":"3566383987360583","name":"Sohws","avatar":"https://static.tigerbbs.com/820619ac430f3da1496aa96b932f4372","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3566383987360583","authorIdStr":"3566383987360583"},"htmlText":"Nice like pls thank you","listText":"Nice like pls thank you","text":"Nice like pls thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/859853154","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6258529,"gmtCreate":1634688931757,"gmtModify":1634693959515,"authorId":3575252907553393,"author":{"id":3575252907553393,"idStr":"3575252907553393","authorId":3575252907553393,"name":"Zhen95","avatar":"https://static.tigerbbs.com/62a4767b8928f124a0f7f02bd3c21f62","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859853154,"type":1,"supId":0,"prevId":0,"content":"gd","text":"gd","html":"gd"},{"id":6258507,"gmtCreate":1634688842964,"gmtModify":1634688843067,"authorId":3569563989023705,"author":{"id":3569563989023705,"idStr":"3569563989023705","authorId":3569563989023705,"name":"rachhy","avatar":"https://static.tigerbbs.com/ac0d9804d3e4fa9220d45c8b779c2019","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859853154,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":859850365,"gmtCreate":1634688523517,"gmtModify":1634688525263,"author":{"id":"3574897713454581","authorId":"3574897713454581","name":"JCai","avatar":"https://static.tigerbbs.com/a4408059854d4abfa5d3e8513d447a16","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3574897713454581","authorIdStr":"3574897713454581"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859850365","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6258387,"gmtCreate":1634688527146,"gmtModify":1634688527175,"authorId":3574897713454581,"author":{"id":3574897713454581,"idStr":"3574897713454581","authorId":3574897713454581,"name":"JCai","avatar":"https://static.tigerbbs.com/a4408059854d4abfa5d3e8513d447a16","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859850365,"type":1,"supId":0,"prevId":0,"content":"<u>mm</u>","text":"<u>mm</u>","html":"<u>mm</u>"}],"langContent":"CN"},{"id":859826727,"gmtCreate":1634688354566,"gmtModify":1634688354801,"author":{"id":"3577607521999934","authorId":"3577607521999934","name":"YCGan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3577607521999934","authorIdStr":"3577607521999934"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859826727","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":859868170,"gmtCreate":1634687745016,"gmtModify":1634687746739,"author":{"id":"4088201880010570","authorId":"4088201880010570","name":"財神發","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"4088201880010570","authorIdStr":"4088201880010570"},"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859868170","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":859817426,"gmtCreate":1634686937736,"gmtModify":1634686937839,"author":{"id":"3586431276580857","authorId":"3586431276580857","name":"Tanwilliam","avatar":"https://static.tigerbbs.com/a15839fa92c1a982981bb380156d5802","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3586431276580857","authorIdStr":"3586431276580857"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/859817426","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6258411,"gmtCreate":1634688618235,"gmtModify":1634688618275,"authorId":3566383987360583,"author":{"id":3566383987360583,"idStr":"3566383987360583","authorId":3566383987360583,"name":"Sohws","avatar":"https://static.tigerbbs.com/820619ac430f3da1496aa96b932f4372","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859817426,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":6257980,"gmtCreate":1634687118281,"gmtModify":1634687118400,"authorId":3559604919356928,"author":{"id":3559604919356928,"idStr":"3559604919356928","authorId":3559604919356928,"name":"stingray102","avatar":"https://static.tigerbbs.com/547c93575fd0fd499d515ad2092a2e9d","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859817426,"type":1,"supId":6257922,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":6257922,"gmtCreate":1634686952800,"gmtModify":1634686952837,"authorId":3580969894464089,"author":{"id":3580969894464089,"idStr":"3580969894464089","authorId":3580969894464089,"name":"okkar","avatar":"https://static.tigerbbs.com/5284953eb6a2c6608eb0336ea3795f46","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":859817426,"type":1,"supId":0,"prevId":0,"content":"✅","text":"✅","html":"✅"}],"langContent":"CN"},{"id":859815259,"gmtCreate":1634686822726,"gmtModify":1634686823416,"author":{"id":"3571889352436684","authorId":"3571889352436684","name":"JoyceChew","avatar":"https://static.tigerbbs.com/bcd2a122cab87882e73eff3dc886ecec","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571889352436684","authorIdStr":"3571889352436684"},"htmlText":"👍🏻👍🏻👍🏻","listText":"👍🏻👍🏻👍🏻","text":"👍🏻👍🏻👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859815259","repostId":2176104937,"repostType":4,"repost":{"id":"2176104937","kind":"news","pubTimestamp":1634686382,"share":"https://ttm.financial/m/news/2176104937?lang=&edition=full","pubTime":"2021-10-20 07:33","market":"us","language":"en","title":"After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176104937","media":"StreetInsider","summary":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of Octobe","content":"<p>After-Hours Stock Movers:</p>\n<p>Sesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food &amp; Drug Administration (FDA) granted <a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a>s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.</p>\n<p>ATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance</p>\n<p>WD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.</p>\n<p><a href=\"https://laohu8.com/S/AKRO\">Akero Therapeutics</a>, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).</p>\n<p>Stride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.</p>\n<p>United Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.</p>\n<p>Netflix&nbsp;(NASDAQ: UAL)&nbsp;1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Sesen Bio,ATI Physical Therapy,WD-40 Co. and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-20 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19079439><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19079439\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRN":"Stride","WDFC":"WD-40","NFLX":"奈飞","AKRO":"Akero Therapeutics","ATIP":"ATI Physical Therapy Inc.","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19079439","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176104937","content_text":"After-Hours Stock Movers:\nSesen Bio (NASDAQ: SESN) 15.8% HIGHER; disclosed: On the morning of October 19, 2021, the US Food & Drug Administration (FDA) granted Sesen Bio, Inc.s (the Company) request for a Type A meeting to discuss the Chemistry, Manufacturing and Controls (CMC) issues raised in the FDAs Complete Response Letter (CRL) regarding the Companys Biologics License Application (BLA) for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (the CMC Type A Meeting). The CMC Type A Meeting has been scheduled for October 29, 2021. During the CMC Type A Meeting, the Company intends to align on a path forward with the FDA related to the CMC issues raised in the CRL.\nATI Physical Therapy (NYSE: ATIP) 14.8% LOWER; Reports Prelim. Q3 Results, Lowers FY Revenue Guidance\nWD-40 Co. (NASDAQ: WDFC) 8.9% LOWER; reported Q4 EPS of $0.61, $0.62 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $115.2 million versus the consensus estimate of $117.47 million.\nAkero Therapeutics, Inc. (Nasdaq: AKRO) 4.1% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program investigating efruxifermin (EFX) for the treatment of non-alcoholic steatohepatitis (NASH).\nStride Inc. (NYSE: LRN) 2.4% HIGHER; reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $400.2 million versus the consensus estimate of $359.48 million. Stride Inc. sees FY2022 revenue of $1.56-1.6 billion, versus the consensus of $1.47 billion.\nUnited Airlines (NASDAQ: UAL) 2.2% HIGHER; reported Q3 EPS of ($1.02), $0.27 better than the analyst estimate of ($1.29). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.85 billion.\nNetflix (NASDAQ: UAL) 1.2% LOWER;Netflix earnings, subscribers get a ‘Squid Game’ bounce, but forecast is tamer.","news_type":1,"symbols_score_info":{"AKRO":0.9,"ATIP":0.9,"LRN":0.9,"NFLX":0.9,"SESN":0.9,"UAL":0.9,"WDFC":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":181,"commentSize":18,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}